United States · Advertising framework
Influencer marketing for diagnostic tests and services in the United States
General market orientation, not campaign clearance. Research scope and dates
Product and service rules
Check the actual device status and advertising jurisdiction
Regulator guidance
Do not equate establishment registration, 510(k) clearance and premarket approval. Restricted-device advertising has specific information and misleading-advertising controls. Assess the exact device, authorised purpose and whether an advertised testing offer is also a clinical service.
Sources: General Controls for Medical Devices
Match the evidence to the precise advertised benefit
Regulator guidance
Applies when: The claim falls within FTC health-advertising oversight; FDA product-specific requirements also need review.
FTC guidance generally expects randomised controlled human clinical testing for health-benefit claims, with design and quality appropriate to the claim and the scientific field. Animal studies or consumer anecdotes alone do not establish human benefits.
Assess the actual formulation, dose, population and outcome. An ingredient study or a clinically tested claim must not imply a proven finished-product effect that the evidence does not support.
Sources: FTC Health Products Compliance Guidance · FTC Health Products Compliance Guidance, substantiation and amount/type of evidence
Channel rules
Review implied claims as well as literal wording
Regulator guidance
FTC guidance assesses the overall impression of health advertising. Hold appropriate scientific evidence before publication; an honest testimonial does not substitute for evidence of the advertised result. Treat imagery and omitted qualifications as part of that assessment.
Disclose a material commercial connection clearly
Regulator guidance
Make payment, free benefits and other material connections clear with the endorsement. Disclosures should be easy to notice and understand, including within videos and repeated where needed in live streams. A profile disclosure or platform tool alone may be insufficient.
Washington health data may be regulated outside HIPAA
Regulator guidance
Applies when: Processing within the scope of Washington’s My Health My Data Act.
Where Washington’s My Health My Data Act applies, collection generally needs purpose-specific consent unless necessary for a requested product or service; sharing requires a distinct consent unless the necessary-service exception applies. Review applicability and exemptions by data and activity, rather than assuming HIPAA status clears advertising tracking. Regulated entities must prominently link a separate consumer health data privacy policy from the homepage.
Sources: Washington consumer-health-data collection and sharing; My Health My Data Act — scope and FAQ
Brief the creator on the permitted message
Editorial recommendation
Check whether endorsements are permitted for the selected offer before contracting a creator. Record payments, gifts and affiliate links; specify the required advertising identification, approved claims, editing controls and takedown process.
State expected results instead of relying on a generic disclaimer
Regulator guidance
FTC guidance says an honest endorsement can still mislead. When a testimonial communicates exceptional results, a generic results-not-typical disclaimer does not cure the impression; disclose the results consumers can generally expect and substantiate the underlying claim.
Sources: FTC Health Products Compliance Guidance · FTC Health Products Compliance Guidance, consumer testimonials and expert endorsements
Campaign workflow
Diagnostics & Health Testing: prepare the review
Editorial recommendation
Separate a test kit, laboratory service, screening package and medical interpretation. State the intended population and explain the limits of a positive or negative result. Review both product rules and provider rules when a device is bundled with a clinical service.
Keep a traceable campaign decision
Editorial recommendation
Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.
Pre-publication checklist
- Separate a test kit, laboratory service, screening package and medical interpretation.
- State the intended population and explain the limits of a positive or negative result.
- Review both product rules and provider rules when a device is bundled with a clinical service.
- Record product or provider eligibility before approving claims.
- Archive the final creative and its evidence, permissions and review decisions.
- Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.
Scope and unresolved questions
- California physician telehealth and Washington consumer-health-data requirements are now documented as scoped examples. Other state medical/dental/pharmacy rules, corporate practice, fee splitting, referral arrangements and state telemarketing laws remain to be assessed for the actual provider and patient location.
- FDA television/radio-format standards and a scoped Washington health-data rule are documented. Exact TCPA revocation implementation dates and post-litigation consent text were not fully verified from accessible primary documents; final SMS clearance remains open. Platform, broadcaster and other state rules depend on the actual execution.
Research scope, introduction and dates
Advertising diagnostic tests and services through influencer collaborations in the United States requires a distinction between the test product, the laboratory service and the interpretation of the result. Use this framework to review those layers and the limits of the advertised outcome.
Creator selection and commercial disclosure are only part of an influencer review. Examine the person's role, the spoken and visual claims, supplied benefits and the final publication together; a personal experience can still communicate a regulated claim.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
How to use this national baseline
Editorial overview
This framework combines researched national rules with editorial review steps. Federal advertising baseline; state professional, pharmacy and privacy rules require a separate review. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.
The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.
Sources
- General Controls for Medical Devices
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- FTC Health Products Compliance Guidance
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- Disclosures 101 for Social Media Influencers
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- Washington consumer-health-data collection and sharing
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
- My Health My Data Act — scope and FAQ
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
From framework to action
Local expertise in United States
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in United States.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
No partners listed in this category yet.
Business & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.